We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy recommendation ... VTSMX - Vanguard Total Stock Market Index Fund Investor ...

GRAIL's groundbreaking Galleri test, detecting 50+ cancers, FDA status, and strategic growth make it a top investment with ...

Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for ...

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 2.79% and 1.46%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Quest Diagnostics Inc.’s stock rose 3% early Tuesday, after the company posted better-than-expected first-quarter earnings ...

U.S. stocks were higher, with the Dow Jones index gaining around 600 points on Tuesday. Shares of Quest Diagnostics ...

Quest Diagnostics (DGX) reports 12% Q1 2025 revenue growth, driven by acquisitions, partnerships, and advanced diagnostics.